Jason Pesile - 03 Jan 2022 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role
Senior Vice President, Finance & Accounting
Signature
Rene Paula Molina, attorney-in-fact for Jason Pesile
Issuer symbol
VAXX
Transactions as of
03 Jan 2022
Transactions value $
$0
Form type
4
Filing time
11 Jan 2022, 14:35:24 UTC
Next filing
04 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAXX Stock Option (right to buy) Award $0 +51.2K $0.00 51.2K 03 Jan 2022 Class A common stock 51.2K $5.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are subject to a four-year time-vesting schedule, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal installments each month during the remainder of the vesting period.

Remarks:

Senior Vice President, Finance & Accounting